Avacincaptad pegol
Medication
- 1 min read
- 2 chapters
Explore on Lably
ToursExplore Lably’s 3D toursAvacincaptad pegol was approved for medical use in the United States in August 2023.
Medical uses
Avacincaptad pegol is indicated for the treatment of geographic atrophy secondary to age-related macular degeneration.
Sign in to keep reading
One more chapter is free with a Lably account.
Society and culture
Avacincaptad pegol is the international nonproprietary name.
More in Health
Food and Drug AdministrationFederal agency of the United States Department of Health and Human ServicesCenters for Disease Control and PreventionUnited States government public health agencyNauseaMedical symptom or conditionSeizurePeriod of symptoms due to excessive or synchronous neuronal brain activityVomitingExpulsion of stomach contents via the mouth or noseIntravenous therapyMedication administered into a vein